Literature DB >> 27541262

Synthesis and in vitro, ex-vivo and in vivo activity of hybrid compounds linking a potent ROS and RNS scavenger activity with diverse substrates addressed to pass across the blood-brain barrier.

Laura Vázquez-Jiménez1, Maria Garrido1, Martina Miceli1, Eva Prats2, Antonio Ferrer-Montiel3, Meritxell Teixidó4, Ciril Jimeno1, Angel Messeguer5.   

Abstract

The synthesis of a small library of CR-6 (a potent ROS and RNS scavenger agent) derivatives bearing covalent linkage with different endogen nutrients that have specific transport through the blood-brain barrier (BBB) is reported. The synthetic sequence involved the preparation of a common precursor ester 6 derived from CR-6, which was easily converted into the carboxylic acid 7a or the amino derivative 11, for its further coupling with the required substrates through amide bonds. Antioxidant in vitro (DPPH) and cellular assays (CAA) with the SH-S5SY cell line performed on these library members revealed that the couplings did not affect the antioxidant activity elicited by CR-6 itself. More interestingly, results from the intraperitoneal administration of selected library components in rats showed that compounds 2b, 2c and 2d were able to pass across the BBB. In particular, the amino acid compound 2d was the most penetrating derivative (15.8 ± 1.7 nmol/g brain with respect to the 4.0 ± 1.2 nmol/g brain found for the parent CR-6).
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antioxidants; Blood-brain barrier permeability; CR-6; Neuroprotective agents; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27541262     DOI: 10.1016/j.ejmech.2016.08.007

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  1 in total

1.  Ultraconserved element uc.333 increases insulin sensitivity by binding to miR-223.

Authors:  Yang Zhang; Jingyu Sun; He Yao; Yajun Lin; Jie Wei; Gang Hu; Jun Guo; Jian Li
Journal:  Aging (Albany NY)       Date:  2020-04-17       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.